Advertisement
Brief report| Volume 24, ISSUE 6, P710-712, October 1988

CSF Somatostatin in alzheimer's disease, depressed patients, and control subjects

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Barclay LL
        • Zemcova A
        • Blass JP
        • Sansone J
        Survival in Alzheimer's disease and vascular dementias.
        Neurology. 1986; 35: 834-840
        • Beal MF
        • Groudon JH
        • Mazurek MF
        • Martin JB
        CSF somatostatin-like immunoreactivity in dementia.
        Neurology. 1986; 36: 294-297
        • Blessed G
        • Tomlinson BE
        • Roth M
        The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects.
        Br J Psychiatry. 1986; 14: 797-811
        • Davies P
        • Terry RD
        Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
        Neurobiol Aging. 1981; 2: 9-14
        • Dupont E
        • Christenson SE
        • Hanson AP
        • et al.
        Low cerebrospinal fluid somatostatin in Parkinson's disease: An irreversible abnormality.
        Neurology. 1982; 32: 312-314
        • Haroutunian VH
        • Mantin R
        • Campbell GP
        • Tsuboyama G
        • Davis KL
        Cysteamine induced depletion of central somatostatin-like immunoactivity: Effects on behavior,learning and brain neurochemistry.
        Brain Res. 1987; 403: 234-242
        • McKhann G
        • Drachman D
        • Folstein F
        • Katzman R
        • Price D
        • Stadlan E
        Clinical diagnosis of Alzheimer's disease.
        Neurology. 1984; 34: 939-943
        • Oram GG
        • Edwardson G
        • Millar PH
        Investigation of cerebrospinal fluid neuropeptides in ediopathic senile dementia.
        J Gerontol. 1981; 27: 216-223
        • Perry EK
        Cortical neurotransmitter chemistry in Alzheimer's disease.
        in: Meltzer H Pharmacology: The Third Generation of Progress. Raven Press, New York1987
        • Reifler BV
        • Larson E
        • Hanley R
        Coexistence of cognitive impairment and depression in geriatric outpatients.
        Am J Psychiatry. 1982; 139: 623-626
        • Rosen WG
        • Mohs RC
        • Davis KL
        A new rating scale for Alzheimer's disease.
        Am J Psychiatry. 1984; 141: 1356-1364
        • Rossor MN
        • Emerson PC
        • Mountjoy CQ
        Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of the Alzheimer type.
        Neurosci Lett. 1980; 20: 373
        • Rubinow DR
        • Gold PW
        • Post RM
        • et al.
        CSF somatostatin in affective illness.
        Arch Gen Psychiatry. 1983; 40: 409-412
        • Schroter E
        Huntington's chorea: Measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.
        J Neurol. 1981; 225: 183-187
        • Serby M
        • Richardson SB
        • Twente S
        • et al.
        CSF somatostatin in Alzheimer's disease.
        Neurobiol Aging. 1984; 5: 187-189
        • Sorenson KV
        • Christensen SE
        • Dupont E
        • et al.
        Low somatostatin content in cerebrospinal fluid in multiple sclerosis.
        Acta Neurol Scand. 1980; 61: 186-191
        • Sunderland T
        • Rubinow DR
        • Tariot PN
        • Cohen RM
        • Newhouse PA
        • Mellow AM
        • Mueller EA
        • Murphy DL
        CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
        Am J Psychiatry. 1987; 144: 1313-1316
        • Wood PL
        • Etienne P
        • Lal S
        • et al.
        Reduced lumbar CSF somatostatin level in Alzheimer's disease.
        Life Sci. 1982; 31: 2073-2079